评论主题：
2003年全球分析仪器排行榜－ABI名列第一
评论对象： equip | 2004-6-20 17:49:00
评论言论： Applied Biosystems led the market in sales of analytical instrumentation and laboratory equipment in calendar 2003,according to Instrumenta’s Industry Scoreboard, a ranking of the top 40suppliers to the analytical instrumenta-tion and laboratory equipment market-place. The full Scoreboard table on pages 2 and 3 lists over 300 further companies by sales ranges.
The company’s sales performance in 2003 was typical of many of the larger US-based companies - in real terms sales growth was low, with the positive effect on international sales of the low dollar helping to boost reported results. Strength in some segments, such as mass spectrometry, was offset by weakness in others, such as consumables, PCR and DNA synthesis/thermocyclers.
Ranked equal with Applied Biosys-tems last year, Thermo Electron reported similar growth to Applied Biosystems but a new evaluation of relevant sales in Thermo Electron’s $1.3 billion Life and Laboratory and $600 million Measurement and Control segments leads us to position the company just behind Applied Biosys- tems, still with sales of over $1.5 billion and still the most diverse product range.
The most significant change in the Scoreboard comes with Shimadzu, which Instrumenta estimates passed $1 billion in analytical sales for the first time, overtaking Waters. Available data shows Shimadzu had a strong year with 9% growth in the first nine months of its fiscal year. In particular the company noted that sales of its mass spectrometers had “substantially exceeded” targets.
Although recording an 8% increase in sales in 2003 thanks to currency effects, Waters could have made a far bigger impact on the scoreboard had it not been for the effects of its lost patent case with Applied Biosys-tems/MDS over mass spectrometry technology. While Applied Biosystems and other competitors saw strong growth in their mass spectrometry businesses, Waters’ sales in this segment declined by 18%. Had it not
been for this, the good growth in Waters HPLC business and a 20% rise in thermal analysis equipment sales would have given Waters an excep－tional year. As it was, the increases were wiped out by the decline in its mass spectrometry business.
The fastest moving company on the list in real terms was MDS Sciex,which saw sales leap 24% to $270 million. Microarray leader Affymetrix surpassed $300 million in sales for the first time. Varian also had a strong year as sales in its Scientific Instru-ments business group grew to over $500 million.
Mergers and acquisitions had very minimal impact at the top of the Score-board in 2003, however there were some noticeable movers and new entrants in the middle tier. These included: Teledyne Instruments, which is continuing to expand its environ-mental monitoring business; Nova Analytics which acquired three electro-chemistry businesses, and Harvard Bioscience, which made five acquisi-tions during the year to build on the acquisitions of Genomic S0lutions and Walden Precision Apparatus in the latter part of 2002.
After a two-year period in which many of the leading companies have been focused on restructuring efforts,many are now looking to renewed growth, both with the market and through acquisition. Deals already announced or completed in late 2003 and early this year will certainly affect the scoreboard for the coming year.
评论对象： equip | 2004-6-20 17:49:00
评论言论： Applied Biosystems led the market in sales of analytical instrumentation and laboratory equipment in calendar 2003,according to Instrumenta’s Industry Scoreboard, a ranking of the top 40suppliers to the analytical instrumenta-tion and laboratory equipment market-place. The full Scoreboard table on pages 2 and 3 lists over 300 further companies by sales ranges.
The company’s sales performance in 2003 was typical of many of the larger US-based companies - in real terms sales growth was low, with the positive effect on international sales of the low dollar helping to boost reported results. Strength in some segments, such as mass spectrometry, was offset by weakness in others, such as consumables, PCR and DNA synthesis/thermocyclers.
Ranked equal with Applied Biosys-tems last year, Thermo Electron reported similar growth to Applied Biosystems but a new evaluation of relevant sales in Thermo Electron’s $1.3 billion Life and Laboratory and $600 million Measurement and Control segments leads us to position the company just behind Applied Biosys- tems, still with sales of over $1.5 billion and still the most diverse product range.
The most significant change in the Scoreboard comes with Shimadzu, which Instrumenta estimates passed $1 billion in analytical sales for the first time, overtaking Waters. Available data shows Shimadzu had a strong year with 9% growth in the first nine months of its fiscal year. In particular the company noted that sales of its mass spectrometers had “substantially exceeded” targets.
Although recording an 8% increase in sales in 2003 thanks to currency effects, Waters could have made a far bigger impact on the scoreboard had it not been for the effects of its lost patent case with Applied Biosys-tems/MDS over mass spectrometry technology. While Applied Biosystems and other competitors saw strong growth in their mass spectrometry businesses, Waters’ sales in this segment declined by 18%. Had it not
been for this, the good growth in Waters HPLC business and a 20% rise in thermal analysis equipment sales would have given Waters an excep－tional year. As it was, the increases were wiped out by the decline in its mass spectrometry business.
The fastest moving company on the list in real terms was MDS Sciex,which saw sales leap 24% to $270 million. Microarray leader Affymetrix surpassed $300 million in sales for the first time. Varian also had a strong year as sales in its Scientific Instru-ments business group grew to over $500 million.
Mergers and acquisitions had very minimal impact at the top of the Score-board in 2003, however there were some noticeable movers and new entrants in the middle tier. These included: Teledyne Instruments, which is continuing to expand its environ-mental monitoring business; Nova Analytics which acquired three electro-chemistry businesses, and Harvard Bioscience, which made five acquisi-tions during the year to build on the acquisitions of Genomic S0lutions and Walden Precision Apparatus in the latter part of 2002.
After a two-year period in which many of the leading companies have been focused on restructuring efforts,many are now looking to renewed growth, both with the market and through acquisition. Deals already announced or completed in late 2003 and early this year will certainly affect the scoreboard for the coming year.
[此贴子已经被作者于2004-6-20 23:28:40编辑过]
